Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Genetic Determinants of Capecitabine Toxicity

NCT00977119 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT00977119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00977119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Genetic Determinants of Capecitabine Toxicity
Lead sponsor
University of Chicago
Phase
Observational
Overall status
Completed
Start date
November 23, 2009
Completion date
June 21, 2021
Enrollment
240 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer